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Introduction
Clinical trial participants in sub-Saharan Africa often have 
limited understanding of the study information provided 
during the informed consent process. Low literacy and the 
difficulty of presenting information in local languages with no 
standard written form are contributory factors.1,2 Nevertheless, 
international ethics guidelines3,4 require informed consent to 
be obtained in a manner that can be understood by individuals 
volunteering for clinical studies. Moreover, the Declaration of 
Helsinki states that special attention should be given to the 
specific information needs of participants and to the methods 
used to deliver that information.4 Consequently, study infor-
mation must be provided in a medium and language under-
stood by potential participants. However, informed consent 
documents are usually written in an official national language, 
often a common international language. In countries such as 
the Gambia, where local languages have no standard writ-
ten form, translating documents into the local language and 
back-translating into the national language (English, in this 
case), to check consistency is both impractical and inaccurate.2
Comprehension of consent information is essential for 
protecting study participants’ rights and for complying with 
the principles of good clinical practice. In sub-Saharan Africa, 
an increasing number of clinical trials are being conducted 
in populations that are vulnerable to exploitation because of 
poverty, illiteracy, social exclusion or poor access to health 
care.5,6 In particular, illiterate participants may not understand 
research concepts, which could undermine their ability to give 
truly informed consent.5 Comprehension could be improved 
using multimedia consent tools that have been effective for 
communicating crucial research information in developed 
countries.7–9 Moreover, empirical studies indicate that such 
tools provide an alternative means of presenting study infor-
mation to vulnerable groups.10,11 The effectiveness of multi-
media consent tools among clinical trial participants with low 
English-language literacy in Africa has not been determined.
Previously in the Gambia, we developed and validated 
both a multimedia tool for providing study information to 
clinical trial participants12 and a computerized, audio question-
naire for assessing their comprehension of informed consent.13 
Here we report on the acceptability, ease of use and effective-
ness of the multimedia tool among participants in a malaria 
treatment trial in the Gambia.
Methods
We conducted a randomized controlled trial in Basse and 
Jahaly Provinces in the Upper River Region and Central River 
Region, respectively, of the Gambia from 15 August 2013 to 12 
March 2014. The study was nested within a parent study – the 
PRINOGAM trial.14 The aim of this trial was to determine the 
optimal dosage of primaquine required to clear gametocytes 
and block disease transmission in asymptomatic malaria car-
riers. Participants in the PRINOGAM trial were aged 1 year 
or older and were seen on the day of inclusion (day 0, the 
Objective To assess the effectiveness of a multimedia informed consent tool for adults participating in a clinical trial in the Gambia.
Methods Adults eligible for inclusion in a malaria treatment trial (n = 311) were randomized to receive information needed for informed 
consent using either a multimedia tool (intervention arm) or a standard procedure (control arm). A computerized, audio questionnaire was 
used to assess participants’ comprehension of informed consent. This was done immediately after consent had been obtained (at day 0) and 
at subsequent follow-up visits (days 7, 14, 21 and 28). The acceptability and ease of use of the multimedia tool were assessed in focus groups.
Findings On day 0, the median comprehension score in the intervention arm was 64% compared with 40% in the control arm (P = 0.042). 
The difference remained significant at all follow-up visits. Poorer comprehension was independently associated with female sex (odds ratio, 
OR: 0.29; 95% confidence interval, CI: 0.12–0.70) and residing in Jahaly rather than Basse province (OR: 0.33; 95% CI: 0.13–0.82). There was 
no significant independent association with educational level. The risk that a participant’s comprehension score would drop to half of the 
initial value was lower in the intervention arm (hazard ratio 0.22, 95% CI: 0.16–0.31). Overall, 70% (42/60) of focus group participants from 
the intervention arm found the multimedia tool clear and easy to understand.
Conclusion A multimedia informed consent tool significantly improved comprehension and retention of consent information by research 
participants with low levels of literacy.
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baseline) and on days 3, 7, 14, 21, 28, 35 
and 42. In the study areas, most residents 
were subsistence farmers and the adult 
literacy rate was about 50%.15
To be included in our study, in-
dividuals had to be eligible for the 
PRINOGAM trial, to be aged 18 years 
or older, to speak and understand one 
of the three major Gambian languages 
(i.e. Mandinka, Fula or Wolof ) and 
to have no obvious communication, 
visual or cognitive impairments. Since 
a systematic review showed that, on 
average, 47% of participants in Afri-
can studies understood basic research 
concepts,1 we estimated that a study 
with a 90% power to detect a 20% dif-
ference between intervention and 
control arms at the 5% significance level 
for a two-sided test would require 137 
participants in each arm. On assuming 
a 10% attrition rate, we estimated that 
approximately 150 participants would 
be required in each group. In our study, 
participants were randomly assigned to 
the intervention or control arm on day 0 
of the PRINOGAM trial, at the time 
of treatment randomization. An inde-
pendent statistician used the RANDI2 
web-based application (available at: 
http://dschrimpf.github.io/randi3/) to 
generate a randomization list for each 
trial site and participants were allocated 
to the intervention or control arm at a 
1:1 ratio with a block size of four. In 
addition, participants were stratified by 
age group and sex.
Intervention
The multimedia informed consent tool 
has been reported in detail elsewhere.12 
Briefly, it contained information from 
the PRINOGAM consent document 
under the headings: (i) introduction; 
(ii) reason for the study; (iii) what 
glucose-6-phosphate dehydrogenase de-
ficiency is; (iv) how to take part; (v) what 
happens if you take part; (vi) what blood 
tests are performed; (vii) what the side-
effects and possible risks of taking part 
are; (viii) what the potential benefits are; 
(ix) how taking part is kept confidential; 
(x) who carried out an ethical review 
of the study; and (xi) who to contact if 
you have questions. The information in 
each section was presented in a context-
specific visual form by members of the 
clinical trial team acting out various 
scenes after training. Video recordings 
were made by a multimedia expert and 
voice-overs were added separately in the 
three main Gambian languages. Adverse 
events of the study drugs that could not 
be adequately presented in the acted 
scenes, such as headache, diarrhoea or 
the passage of dark-coloured urine, were 
illustrated using animations.12 In addi-
tion, the multimedia tool was tailored 
to the cultural and linguistic diversity 
of the Gambian population. A digital 
versatile disc (DVD) incorporating the 
three language versions was produced 
and uploaded onto laptop computers. 
For the intervention arm of our study, 
a trained field assistant selected the 
language preferred by each participant 
and played the DVD using a laptop 
computer in a quiet room. Individuals 
consented to participating in the trial 
by either signing or thumb-printing 
the consent form in the presence of an 
impartial witness.
In the control arm, clinical trial 
information was presented using the 
Fig. 1. Flowchart for participants in the study of comprehension of informed consent, 
the Gambia, 2013–2014
156 randomized to the 
control group
149 completed all 
study visits
155 randomized to the 
intervention group
150 completed all 
study visits
347 participants enrolled into the PRINOGAM trial in 
Basse and Jahaly provinces
311 participants agreed to join the multimedia 
informed consent tool study
36 excluded:
• 26 refused to take part
• 10 insisted on using the multimedia 
tool without going through 
randomization
Fig. 2. Informed consent comprehension questionnaire scoresa in intervention and 
control armsb at baseline,c the Gambia, 2013–2014
P = 0.042
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a  The box shows the values of the median and the first and third quartiles, the whiskers represent 1.5 
times the interquartile range above and below the median and the small circles indicate outliers.
b  In the intervention arm, participants were informed about the trial using a multimedia informed 
consent tool; in the control arm, trial information was presented using current standard practice.
c  Baseline was day 0 of the parent treatment trial.
Bull World Health Organ 2015;93:320–328A| doi: http://dx.doi.org/10.2471/BLT.14.146159322
Research
Multimedia informed consent tool, the Gambia Muhammed Olanrewaju Afolabi et al. 
current standard practice accepted by 
the national ethics committee in the 
Gambia (chair of the Gambia’s National 
Ethics Committee, personal communi-
cation, 12 October 2010). In the absence 
of acceptable written versions of the 
local languages, the study’s principal 
investigator trained field staff, who were 
native speakers of the major local lan-
guages, on the correct interpretation of 
the English version of the participants’ 
information sheet. Subsequently, the 
study information was presented ver-
bally to prospective participants during 
discussions on informed consent. Again, 
consent was given by either signing or 
thumb-printing the consent form.2,16
Assessment
We have previously shown that the 
computerized, audio, informed consent 
comprehension questionnaire is a reli-
able and valid tool for assessing com-
prehension of informed consent among 
Gambian trial participants.13 It com-
prises 26 questions in the three major 
Gambian languages: nine open-ended, 
seven closed-ended and 10 multiple-
choice questions. The questionnaire was 
administered using laptop computers 
by trained interviewers who entered 
participants’ responses to each question. 
Responses were automatically recorded 
in the questionnaire computer database.
Comprehension was assessed on 
the basis of recall and understanding.17 
Recall relates to the participant’s ability 
to correctly answer closed-ended and 
multiple-choice questions. Understand-
ing is defined as the participant’s ability 
to correctly interpret or respond to open-
ended questions. Our primary study 
outcome was comprehension of consent 
information as indicated by the partici-
pant’s questionnaire score, expressed as 
a percentage, on day 0 at study inclusion. 
Secondary outcomes were comprehen-
sion on days 7, 14, 21 and 28.
In addition, 119 randomly selected 
participants took part in focus group 
discussions on day 35, to further explore 
understanding of the PRINOGAM trial 
and to evaluate the acceptability and 
ease of use of the multimedia tool. Ten 
focus group discussion sessions were 
held in Basse Province; only six were 
held in Jahaly Province because there 
were fewer participants. Seven or eight 
participants were invited to each ses-
sion and participants were segregated 
by sex so they could express their views 
more easily. The sessions were facilitated 
using a specially designed focus group 
discussion guide (available from cor-
responding author). Audio recordings 
of the sessions were transcribed into 
English by three translators and the ac-
curacy of the translations was confirmed 
by independent translators fluent in 
the local languages and English. The 
transcribed texts were analysed using 
NVivo version 10.0 (QSR International 
Pty. Ltd, Doncaster, Australia) and the 
main themes that emerged were coded 
line by line to elucidate their mean-
ings. The themes were subsequently 
sorted and collated into categories and 
subcategories and themes from the two 
sites were compared, integrated and 
refined. Finally, selected quotations 
from participants were used to illustrate 
differences in understanding of consent 
information between the intervention 
and control arms.
Statistical analysis
Because data on comprehension of 
consent information were not normally 
distributed, we compared the median 
and interquartile range of participants’ 
comprehension scores at each visit in the 
two study arms. Associations between 
participants’ characteristics and baseline 
comprehension scores were assessed 
using the Mann–Whitney U test if the 
characteristic was classified using two 
categories and the Kruskal–Wallis test 
if more than two categories were used. 
We used forward stepwise variable 
selection in a multivariate logistic re-
gression analysis to identify factors that 
were associated with comprehension on 
day 0. For this purpose, we reclassified 
the comprehension scores as a binary 
variable equal to 2 (below median) or 
1 (median or above). Since participants 
were recruited at two different sites, we 
investigated the effect of clustering on 
comprehension using a mixed-effects 
model. Survival analysis was used to 
extrapolate the decline in comprehen-
sion scores beyond the end of the study 
follow-up. A P-value less than 0.05 was 
regarded as statistically significant. All 
statistical calculations were performed 
using Stata version 12.1 (StataCorp. 
LP, College Station, United States of 
America).
Approval was obtained from the 
ethics committee of the London School 
of Hygiene & Tropical Medicine in 
the United Kingdom of Great Britain 
Fig. 3. Informed consent comprehension questionnaire scoresa in intervention and 
control armsb at day 7,c the Gambia, 2013–2014
P = 0.051
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a  The box shows the values of the median and the first and third quartiles, the whiskers represent 1.5 
times the interquartile range above and below the median and the small circles indicate outliers.
b  In the intervention arm, participants were informed about the trial using a multimedia informed 
consent tool; in the control arm, trial information was presented using current standard practice.
c  Day 7 of the parent treatment trial.
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and Northern Ireland and the Gam-
bian Government–Medical Research 
Council Joint Ethics Committee. The 
trial was registered with the Pan Afri-
can Clinical Trials Registry (PACTR 
201402000775274).
Results
Of the 347 participants enrolled in the 
PRINOGAM trial, 26 refused to take 
part (7.5%) in the study of the multi-
media informed consent tool. Most of 
those who refused said they did not 
have time to wait because of domestic 
demands. In addition, 10 participants 
(2.9%) insisted on using the multimedia 
tool without going through randomiza-
tion, most likely because they had heard 
about the tool through friends or family 
already enrolled in the study. After ex-
cluding these 36 participants, 311 were 
enrolled in the study and included in 
final analysis (Fig. 1). Table 1 (available 
at: http://www.who.int/bulletin/vol/-
umes/93/5/14-146159) shows there was 
no significant difference in demographic 
characteristics at baseline between 
participants in the two study arms. The 
playing time of the multimedia DVD 
was 19.4 minutes and the standard 
consent process took 30 to 35 minutes 
depending on the communication skills 
and experience of the research assistant 
providing the information. On average, 
question-and-answer sessions after the 
consent interviews took 32 minutes.
The median consent comprehen-
sion score of participants who used the 
multimedia tool was higher at all times 
points than those who received informa-
tion using current standard practice. For 
example, at day 0 (Fig. 2), the median 
comprehension score in the interven-
tion arm was 64% compared with 40% 
in the control arm (P = 0.042). The cor-
responding comparisons for days 7, 14, 
21 and 28 are shown in Fig. 3, Fig. 4, 
Fig. 5 and Fig. 6, respectively. Table 2 
shows that comprehension of informed 
consent at baseline in the two study 
arms combined was significantly greater 
in male participants, those who resided 
in Basse province and those who had 
received formal education based on an 
English-language curriculum. In ad-
dition, multivariate logistic regression 
analysis found that, after controlling for 
other covariates, poorer comprehension 
at baseline was significantly and indepen-
dently associated with female sex (odds 
ratio, OR: 0.29; 95% confidence interval, 
CI: 0.12–0.70) and residing in Jahaly 
province (OR: 0.33; 95% CI: 0.13–0.82; 
Table 3). However, on applying the 
mixed-effects model, place of residence 
was no longer significantly associated 
with comprehension at baseline (OR: 
0.85; 95% CI: 0.45–1.60; details available 
from authors). Survival analysis showed 
that the risk that a participant’s compre-
hension score would, during follow-up, 
drop to below 50% of that at day 0 was 
lower in the intervention arm than the 
control arm (hazard ratio 0.22, 95% CI: 
0.16–0.31; details available from authors). 
Extrapolating beyond the end of follow-
up indicated that the estimated median 
time for the comprehension score to drop 
below 50% was 67.0 days in the interven-
tion arm compared with 40.6 days in the 
control arm (P < 0.0001). A summary of 
the economic and financial costs of devel-
oping and administering the multimedia 
informed consent tool is available from 
corresponding author.
Focus group discussions
The 119 participants in the focus groups 
were aged between 23 and 47 years, 60 
were in the intervention arm and 59 
were in the control arm, 79 were female 
and 40 were male, and 56 resided in 
Basse Province and 63 resided in Jahaly 
Province. In Basse, 69.6% were female 
compared with 63.4% in Jahaly.
Informed consent
There was general consensus that sign-
ing or thumb-printing the consent form 
implied a commitment to participate 
in the research. One participant from 
Basse said, “When you put your hand 
in that paper, then you have promised 
to be part of the study.” However, there 
were divergent opinions on the right to 
withdraw. Whereas most participants 
in the control arm felt strongly that it 
was morally wrong to stop participating 
before the end of the study, the majority 
in the intervention arm stated that par-
ticipants were free to leave at any time. 
One participant in the intervention arm 
said, “What we always think is that our 
doctors will be angry if we leave before 
the end of the study, but I now know 
after watching the ‘film’ that we have 
freedom to leave at any time, without 
telling them the reason for this… ”
Participants were unequivocal that 
incentives were needed to motivate them 
to join and stay in the trial. Whereas 
Fig. 4. Informed consent comprehension questionnaire scoresa in intervention and 
control armsb at day 14,c the Gambia, 2013–2014
P = 0.035
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a  The box shows the values of the median and the first and third quartiles, the whiskers represent 1.5 
times the interquartile range above and below the median and the small circles indicate outliers.
b  In the intervention arm, participants were informed about the trial using a multimedia informed 
consent tool; in the control arm, trial information was presented using current standard practice.
c  Day 14 of the parent treatment trial.
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the majority considered the benefits of 
participation to be free medical care, 
a minority also wanted fertilizers and 
sponsorship of their children’s educa-
tion. One said, “We appreciate all the 
good things you have done to care for us 
and our children, but the real help that 
we expect and will never be forgotten is 
to give us fertilizers for our crops and 
train our children to be like you....” Most 
participants in the control arm could not 
describe the risks involved, whereas par-
ticipants in the intervention arm could 
often name the adverse events associ-
ated with the study medications, such 
as headache, abdominal pain, vomiting 
and diarrhoea. A male participant in the 
intervention arm described the passage 
of dark-coloured urine associated with 
haemolysis caused by primaquine in 
individuals with glucose-6-phosphate 
dehydrogenase deficiency, as urinating 
“wonjo”. “Wonjo” is a popular, local, 
dark-red coloured, hibiscus drink. Most 
participants in the intervention arm 
described the randomization procedure 
graphically and some participants in the 
control arm said randomization was 
done to ensure all participants had an 
equal chance of participating.
Multimedia informed consent tool
Overall, 70% (42/60) of focus group 
participants from the intervention arm 
thought the visual and verbal information 
presented through the DVD was clear and 
easy to understand. However, a few ex-
pressed reservations. One said, “Although 
I like the (computer) pictures and sounds, 
I prefer face-to-face talking. I can easily 
ask questions that are not clear to me and 
this will make me understand better.” An-
other said, “The Fula man (interpreter) on 
the computer (video) repeated the same 
information over and over, and this made 
everything boring to me.”
Discussion
Our study’s findings confirm that use 
of a multimedia informed consent tool 
results in significantly better under-
standing of clinical trial information 
than the current standard method for 
obtaining consent. Participants using 
the multimedia tool achieved signifi-
cantly higher consent comprehension 
scores at all study assessments. More-
over, results indicated that those who 
used the multimedia tool retained the 
study information significantly longer.
Fig. 5. Informed consent comprehension questionnaire scoresa in intervention and 
control armsb at day 21,c the Gambia, 2013–2014
P = 0.039
Study arm
Intervention Control
In
fo
rm
ed
 co
ns
en
t c
om
pr
eh
en
sio
n 
qu
es
tio
nn
ai
re
 sc
or
e (
%
)
100
80
60
40
20
0
a  The box shows the values of the median and the first and third quartiles, the whiskers represent 1.5 
times the interquartile range above and below the median and the small circles indicate outliers.
b  In the intervention arm, participants were informed about the trial using a multimedia informed 
consent tool; in the control arm, trial information was presented using current standard practice.
c  Day 21 of the parent treatment trial.
Fig. 6. Informed consent comprehension questionnaire scoresa in intervention and 
control armsb at day 28,c the Gambia, 2013–2014
P = 0.045
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a  The box shows the values of the median and the first and third quartiles, the whiskers represent 1.5 
times the interquartile range above and below the median and the small circles indicate outliers.
b  In the intervention arm, participants were informed about the trial using a multimedia informed 
consent tool; in the control arm, trial information was presented using current standard practice.
c  Day 28 of the parent treatment trial.
Bull World Health Organ 2015;93:320–328A| doi: http://dx.doi.org/10.2471/BLT.14.146159 325
Research
Multimedia informed consent tool, the GambiaMuhammed Olanrewaju Afolabi et al. 
Although education, place of resi-
dence and sex were associated with 
participants’ comprehension scores at 
baseline, multivariate analysis found 
that the associations were significant 
only for place of residence and sex. 
This contrasts with findings of previous 
studies, which reported that educational 
level was an independent predictor of 
comprehension.18,19 The difference may 
have arisen because the large majority 
of our study participants had no formal 
education, which further strengthens 
the case for using multimedia tools to 
provide information to participants 
with low levels of literacy. Moreover, 
the multimedia tool was well received: 
in fact, during recruitment some partici-
pants insisted on being allocated to the 
intervention arm without undergoing 
formal randomization. Also, in focus 
group discussions, participants said they 
liked the way the study information was 
presented visually and verbally through 
the multimedia tool.
Our study adds to the emerging 
body of evidence that multimedia tools 
can increase trial participants’ compre-
hension of informed consent in Africa, 
particularly in areas where low literacy 
is common.10,11 In our study, research 
concepts that are known to be difficult 
to understand were clearly illustrated 
Table 2. Influence of sociodemographic characteristics on comprehension of informed consent at baseline, the Gambia, 2013–2014
Characteristic Informed consent comprehension questionnaire score, median (IQR) Pa
Intervention (n = 155) Control (n = 156)
Age, years 0.54b
18–40 68.0 (63.0–73.0) 40.5 (33.5–46.5) NA
≥ 41 65.0 (61.0–72.0) 43.0 (35.5–53.0) NA
Sex 0.032b
Male 68.0 (65.0–73.0) 45.0 (38.0–51.0) NA
Female 67.0 (61.0–72.0) 39.0 (33.0–46.0) NA
Place of residence 0.021b
Basse province 67.5 (63.0–73.0) 44.0 (39.0–51.0) NA
Jahaly province 67.0 (61.0–74.0) 33.0 (30.0–38.0) NA
Educationc 0.0049b
Formal education 66.5 (61.0–72.0) 40.0 (33.0–48.0) NA
No formal education 70.0 (65.0–74.0) 45.0 (40.0–47.0) NA
Language of assessment 0.92d
Mandinka 67.0 (64.0–73.0) 41.0 (33.0–47.0) NA
Fula 69.0 (61.0–74.0) 38.0 (30.0–45.0) NA
Wolof e 67.5 (62.0–73.0) 42.0 (35.0–50.0) NA
Previous clinical trial participation 0.21d
Yes 67.0 (63.0–73.0) 41.0 (34.0–48.0) NA
No 69.0 (65.0–72.0) 40.0 (33.0–47.0) NA
Don’t know 48.0 (48.0–48.0) 43.0 (43.0–43.0) NA
IQR: interquartile range; NA: not applicable.
a  The P-value is for the significance of the influence of the sociodemographic characteristic on the participants’ comprehension of informed consent at baseline in the 
two arms combined.
b  The P-value for the significance of the association between the sociodemographic characteristic and baseline comprehension scores was assessed using the Mann–
Whitney U test when there were two categories for the characteristic.
c  For the purposes of this study, the term “formal education” was defined as education based on an English-language curriculum that involved the completion of 
primary school, with or without 3 years of junior secondary school.
d  The P-value for the significance of the association between the sociodemographic characteristic and baseline comprehension scores was assessed using the 
Kruskal–Wallis test when there were more than two categories for the characteristic.
e  Included participants of Sarahule and Manjago ethnicities.
Table 3. Influence of sociodemographic characteristics on comprehension of informed 
consent at baseline, by multivariate logistic regression analysis, the Gambia, 
2013–2014
Characteristic Likelihood of better comprehension of 
informed consent,a OR (95% CI)
Age group (18–40 years versus > 41 years) 1.41 (0.62–3.21)
Female versus male 0.29 (0.12–0.70)
Resident of Jahaly province vs Basse province 0.33 (0.13–0.82)
Formal education versus no formal educationb 0.67 (0.23–1.93)
Assessment language: (Mandinka vs Wolof and Fula) 0.56 (0.29–1.08)
Previous trial participation versus no previous trial 
participation
1.07 (0.42–2.73)
CI: confidence interval; OR: odds ratio.
a  Better comprehension of informed consent was defined as an informed consent comprehension 
questionnaire score above the median for the intervention or control group, as appropriate.
b  For the purposes of this study, the term “formal education” was defined as education based on an English-
language curriculum that involved the completion of primary school, with or without 3 years of junior 
secondary school.
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摘要
冈比亚境内研究参与者的多媒体同意工具：随机对照试验
目的 旨在针对冈比亚境内参与临床试验的成年人评价
多媒体知情同意工具的有效性。
方法 随机选出有资格参与疟疾治疗试验 (n = 311) 的成
年人，让其通过多媒体工具（干预组）或标准程序（控
制组）接收知情同意所需的信息。使用经过电脑处理
的音频调查问卷有助于评价参与者对知情同意的理
解。获得同意后会立即（第 0 天）并在随后的后续访
问（第 7、14、21 和 28 天）中完成这一过程。多媒体
工具的可接受性和易用性会在重点小组中进行评价。
结果 第 0 天，干预组的理解评分中值为 64%，控制组
为 40% (P = 0.042)。在所有后续访问中保持显著差异。
理解不足与女性性别具有独立相关性（让步比，或 ：
0.29 ；95% 置信区间，CI ：0.12–0.70）并且其住在加
哈利 (Jahaly) 而非巴塞 (Basse) 省（或 ：0.33 ；95% CI ：
0.13–0.82）。与教育水平并无显著的独立相关性。干
预组中参与者的理解评分在可能会下降至初始值一半
这方面的风险较低（风险比为 0.22，95% CI：0.16–0.31）。
整体来说，干预组中 70% (42/60) 的重点小组参与者能
够明确多媒体工具并且容易理解。
结论 多媒体知情同意工具能大大提高具有较低文化水
平的研究参与者对知情信息的理解和记忆。
using video recordings and animations 
and clearly explained by sound tracks 
in three local languages. Furthermore, 
we nested our study within a malaria 
treatment trial to ensure that our find-
ings were relevant to trials carried out in 
real-life settings, whereas previous stud-
ies conducted outside Africa adopted a 
simulated study design.8,9
The first limitation of our study was 
that, since our centre has been conduct-
ing research projects in the Gambia for 
more than 60 years, the local population 
was familiar with research projects. 
The effectiveness of the multimedia 
tool may be different in areas where the 
population is less familiar with research. 
Second, there was some clustering of 
participants: around two-thirds were 
recruited in Basse province, where the 
prevalence of asymptomatic malaria 
infection was higher than in Jahaly prov-
ince. However, sociodemographic and 
epidemiological characteristics were 
similar at the two sites. Moreover, the 
mixed-effects model showed that place 
of residence had no significant effect on 
comprehension, which suggests that the 
effect of clustering was not significant.
In conclusion, our multimedia tool 
improved trial participants’ comprehen-
sion and retention of information about 
informed consent in an area of the Gam-
bia with low levels of literacy. Such tools 
can help address the fundamental ethical 
challenge of obtaining informed consent 
from individuals in these settings. ■
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صخلم
دهاوشلاب ةطبضم ةاشعم ةبرتج :ايبماغ في ثحبلا في ينكراشملل طئاسولا ةددعتم ةيرنتسم ةقفاوم ةادأ
 ةكراشلم طئاسولا ةددعتم ةيرنتسم ةقفاوم ةادأ ةيلعاف مييقت ضرغلا
 .ايبماغ في ةيريسر ةبرتج في ينغلابلا
 جلاع  ةبرتج  في  ةكراشملل  ينلهؤلما  ينغلابلا  رايتخا  مت  ةقيرطلا
 ةمزلالا تامولعلما يقلتل يئاوشع لكشب )311 = ددعلا( ايرلالما
 )لخدتلا عارذ( طئاسولا ةددعتم ةادأ مادختساب ةيرنتسلما ةقفاوملل
 تيوص  نايبتسا  مادختسا  مت  .)ةرطيسلا  عارذ(  يرايعم  ءارجإ  وأ
 كلذ ءارجإ  مت  .ةيرنتسلما  ةقفاوملل  ينكراشلما  مهف  مييقتل  بسومح
 ةعباتم تارايز فيو )0 موي في( ةقفاولما لىع لوصلحا دعب روفلا لىع
 ةلوهسو  ةيلوبقم  مييقت  مت  .)28و  21و  14و  7  مايأ  في(  ةقحلا
.زيكترلا تاعوممج في طئاسولا ةددعتم ةادلأا مادختسا
 64% لخدتلا عارذ في مهفلا ةجرد طسوتم لجس ،0 موي في جئاتنلا
 لظ .)0.042 = لماتحلاا( ةرطيسلا عارذ في 40% ةجردب ةنراقم
 لكشب لقلأا مهفلا طبترا .ةعباتلما تارايز عيجم في ًايربك فلاتخلاا
 اهرادقم  ةيحجرأ  ةبسنب  ؛0.29  :لماتحلاا  ةبسن(  ثانلإاب  لقتسم
 سياب ةعطاقم نم رثكأ لياهاج في ينميقلماو )0.70 لىإ 0.12 :95%
 لىإ 0.13 :95% اهرادقم ةيحجرأ ةبسنب ؛0.33 :لماتحلاا ةبسن(
 .يميلعتلا  ىوتسلماب  يربك  لقتسم  طابترا  كانه  نكي  لم  .)0.82
 ةميقلا  فصن  لىإ  كراشلما  ىدل  مهفلا  ةجرد  ضافخنا  رطخ  ناك
 ةيحجرأ ةبسنب ،0.22 ةروطلخا ةبسن( لخدتلا عارذ في لقأ ةيلولأا
 نم 70%  دجو ،لياجمإ لكشب .)0.31  لىإ 0.16 :95%  اهرادقم
 ةادلأا نأ لخدتلا عارذ في زيكترلا ةعومجمب )60/42( ينكراشلما
.مهفلا ةلهسو ةحضاو طئاسولا ةددعتم
 نم ةدشب طئاسولا ةددعتم ةيرنتسلما ةقفاولما ةادأ ترّوط جاتنتسلاا
 ثحبلاب ينكراشلما بناج نم ابه ظافتحلااو ةقفاولما تامولعم مهف
 .ةباتكلاو ةءارقلاب مالملإا نم ةضفخنم تايوتسم ميهدل نمم
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Résumé
Outil multimédia de consentement pour les participants à des recherches en Gambie : un essai contrôlé randomisé
Objectif Évaluer l’efficacité d’un outil multimédia de consentement 
éclairé pour les adultes participant à un essai clinique en Gambie.
Méthodes Les adultes éligibles à la participation à un essai de 
traitement du paludisme (n = 311) ont été randomisés pour le recueil des 
informations nécessaires au consentement éclairé, au moyen d’un outil 
multimédia (branche d’intervention) ou bien de la procédure standard 
(branche témoin). Un questionnaire audio informatisé a été utilisé pour 
évaluer la compréhension du consentement éclairé par les participants, 
immédiatement après l’obtention de ce consentement (jour 0) ainsi que 
lors des visites de suivi ultérieures (jours 7, 14, 21 et 28). L’acceptabilité 
et la facilité d’utilisation de cet outil multimédia ont été évaluées dans 
des groupes de discussions.
Résultats Au jour 0, le score médian de compréhension dans la 
branche d’intervention était de 64% contre 40% dans la branche 
témoin (P = 0,042). La différence est restée significative lors de toutes 
les visites de suivi. Les difficultés de compréhension étaient associées 
indépendamment au sexe féminin (rapport des cotes, RC : 0,29 ; 
intervalle de confiance de 95%, IC : 0,12–0,70) et au fait de résider dans 
la province de Jahaly plutôt que dans celle de Basse (RC : 0,33 ; IC de 
95% : 0,13–0,82). Aucune association indépendante significative avec 
le niveau d’éducation n’a été observée. Le risque de voir le score de 
compréhension d’un participant baisser de moitié par rapport à sa valeur 
initiale était plus faible dans la branche d’intervention (ratio de risque 
0,22, IC de 95% : 0,16-0,31). Globalement, 70% (42/60) des participants 
du groupe de discussion de la branche d’intervention ont trouvé l’outil 
multimédia clair et facile à comprendre.
Conclusion L’outil multimédia de consentement éclairé a sensiblement 
amélioré la compréhension et la mémorisation des informations sur 
le consentement par les participants à des recherches ayant un faible 
niveau d’alphabétisation.
Резюме
Использование мультимедийного инструмента для получения согласия от участников исследований в 
Гамбии: рандомизированное контролируемое исследование
Цель Оценить эффективность мультимедийного инструмента, 
предназначенного для получения информированного согласия 
взрослых на участие в клиническом исследовании в Гамбии.
Методы Взрослые, соответствующие критериям для включения 
в исследование по лечению малярии (n = 311), были случайным 
образом распределены в две группы. Одна группа получала 
информацию, необходимую для их информированного согласия, 
с помощью специального мультимедийного инструмента 
(экспериментальная группа), в другой группе использовалась 
стандартная процедура (группа сравнения). Для оценки 
понимания информированного согласия участниками 
исследования использовался компьютерный аудиоопросник. 
Оценка проводилась сразу же после получения согласия 
участника (день 0) и во время последующих контрольных визитов 
(дни 7, 14, 21 и 28). Приемлемость и простота использования 
мультимедийного инструмента оценивались в фокус-группах.
Результаты В день 0 средний балл понимания в экспериментальной 
группе составил 64 % по сравнению с 40 % в группе сравнения 
(P = 0,042). Разница оставалась значительной по результатам 
всех последующих визитов. Более низкий уровень понимания 
отмечался среди женщин (отношение шансов, ОШ: 0,29; 
95% доверительный интервал, ДИ: 0,12–0,70) и проживающих 
в Джахалы в сравнении с провинцией Бассе (ОШ: 0,33; 95% ДИ: 
0,13–0,82). Существенная зависимость от уровня образования 
не наблюдалась. Риск того, что уровень понимания участником 
сократится в два раза в сравнении с первоначальной оценкой, 
в экспериментальной группе был ниже (отношение рисков 0,22, 
95% ДИ: 0,16–0,31). В целом 70 % (42/60) участников фокус-группы 
из экспериментальной группы заявили, что мультимедийный 
инструмент является понятным и простым в использовании.
Вывод  Мультимедийный инструмент для получения 
информированного согласия значительно улучшил понимание 
и запоминание условий согласия среди участников с низким 
уровнем грамотности.
Resumen
Una herramienta multimedia para el consentimiento para los participantes en la investigación en Gambia: un ensayo 
controlado aleatorizado
Objetivo Evaluar la eficacia de una herramienta multimedia para el 
consentimiento informado para los adultos que participan en un ensayo 
clínico en Gambia.
Métodos Los adultos elegibles para ser incluidos en un ensayo de 
los tratamientos de la malaria (n = 311) fueron aleatorizados para 
recibir la información necesaria para el consentimiento informado 
mediante una herramienta multimedia (brazo de intervención) o un 
procedimiento estándar (brazo de control). Se utilizó un cuestionario de 
audio electrónico para evaluar la comprensión de los participantes del 
consentimiento informado. Esto se realizó inmediatamente después de 
la obtención del consentimiento (el día 0) y en las visitas de seguimiento 
posteriores (días 7, 14, 21 y 28). La aceptación y facilidad de uso de la 
herramienta multimedia se evaluó en grupos muestrales.
Resultados En el día 0, la puntuación de comprensión media en el 
brazo de intervención fue del 64%, en comparación con el 40% en el 
brazo de control (P = 0,042). La diferencia siguió siendo significativa 
en todas las visitas de seguimiento. La peor comprensión se relacionó 
independientemente con el sexo femenino (cociente de posibilidades, 
CP: 0,29; 95% intervalo de confianza, IC: 0,12–0,70) y con los residentes 
en Jahaly en lugar de la provincia de Basse (CP: 0,33 (95% IC: 0,13–0,82). 
No hubo ninguna asociación independiente significativa con el nivel 
educativo. El riesgo de que la puntuación de comprensión de un 
participante se redujese a la mitad de la puntuación inicial era menor 
en el brazo de intervención (cociente de riesgos instantáneos 0,22, 95% 
IC: 0,16–0,31). En términos generales, el 70% (42/60) de los participantes 
del grupo muestral del brazo de intervención consideraron que la 
herramienta multimedia era clara y fácil de entender.
Conclusión Una herramienta multimedia para el consentimiento 
informado mejoró considerablemente la comprensión y retención de 
la información consentida por los participantes en la investigación con 
bajos niveles de alfabetización.
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Table 1. Sociodemographic characteristics of study participants in randomized controlled trial of a multimedia consent tool, the 
Gambia, 2013–2014
Characteristic No. (%) P
Intervention arma (n = 155) Control arma (n = 156)
Age, years 0.247
18–25 23 (14.8) 35 (22.4) NA
26–33 50 (32.3) 44 (28.2) NA
34–41 40 (25.8) 35 (22.4) NA
42–49 28 (18.1) 34 (21.8) NA
> 49 14 (9.0) 8 (5.1) NA
Sex 0.692
Female 96 (61.9) 100 (64.1) NA
Male 59 (38.1) 56 (35.9) NA
Place of residence  0.443
Basse province 102 (65.8) 109 (69.9) NA
Jahaly province 53 (34.2) 47 (30.1) NA
Ethnicity 0.666
Mandinka 75 (48.4) 81 (51.9) NA
Fula 66 (42.6) 62 (39.7) NA
Wolof 8 (5.2) 5 (3.2) NA
Sarahule 5 (3.2) 7 (4.5) NA
Manjago 1 (0.7) 1 (0.6) NA
Educationb 0.097
Formal education 41 (26.5) 29 (18.6) NA
No formal education 114 (73.5) 127 (81.4) NA
Religious affiliation 0.995
Islam 153 (98.7) 154 (98.7) NA
Christianity 2 (1.3) 2 (1.3) NA
Previous clinical trial participation 0.071
Yes 14 (9.0) 28 (18.0) NA
No 140 (90.3) 127 (81.4) NA
Don’t know 1 (0.7) 1 (0.6) NA
NA: not applicable.
a  In the intervention arm, study participants were informed about the clinical trial using a multimedia informed consent tool; in the control arm, information was 
provided using the current standard method for informed consent.
b  For the purposes of this study, the term “formal education” was defined as education based on an English-language curriculum that involved the completion of 
primary school, with or without 3 years of junior secondary school.
